Virtu Financial LLC Anavex Life Sciences Corp. Transaction History

Virtu Financial LLC

$1.31 Billion
Q1 2024

A detailed history of Virtu Financial LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Virtu Financial LLC holds 40,612 shares of AVXL stock, worth $167,321. This represents 0.02% of its overall portfolio holdings.

Number of Shares

40,612

Previous 21,658 87.52%

Holding current value

$167,321

Previous $202,000 2.48%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$4.55 - $6.75 $86,240 - $127,939	18,954 Added 87.52%	40,612 $207,000
Q4 2023 Feb 26, 2024	BUY	$5.04 - $9.95 $109,156 - $215,497	21,658 New	21,658 $202,000
Q2 2023 Jul 27, 2023	SELL	$7.66 - $9.5 $435,532 - $540,151	-56,858 Reduced 83.17%	11,507 $94,000
Q1 2023 May 01, 2023	BUY	$8.32 - $11.75 $322,408 - $455,324	38,751 Added 130.85%	68,365 $586,000
Q4 2022 Feb 15, 2023	BUY	$7.65 - $14.43 $226,547 - $427,330	29,614 New	29,614 $274,000

Q1 2022 May 17, 2022	SELL	$9.74 - $17.69 $151,194 - $274,601	-15,523 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$16.88 - $23.31 $262,028 - $361,841	15,523 New	15,523 $269,000
Q3 2021 Nov 12, 2021	SELL	$16.82 - $25.75 $1.36 Million - $2.09 Million	-81,011 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$10.16 - $28.86 $823,071 - $2.34 Million	81,011 New	81,011 $1.85 Million
Q1 2021 May 19, 2021	SELL	$5.17 - $16.13 $77,808 - $242,756	-15,050 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$4.01 - $7.58 $62,940 - $118,975	-15,696 Reduced 51.05%	15,050 $81,000
Q3 2020 Dec 11, 2020	BUY	$3.8 - $5.0 $67,803 - $89,215	17,843 Added 138.29%	30,746 $140,000
Q2 2020 Aug 07, 2020	SELL	$2.62 - $5.2 $55,103 - $109,366	-21,032 Reduced 61.98%	12,903 $63,000
Q4 2019 Feb 04, 2020	SELL	$2.31 - $3.14 $38,124 - $51,822	-16,504 Reduced 32.72%	33,935 $88,000
Q3 2019 Nov 20, 2019	BUY	$2.22 - $3.9 $111,974 - $196,712	50,439 New	50,439 $159,000
Q2 2019 Aug 13, 2019	SELL	$2.75 - $3.7 $136,345 - $183,446	-49,580 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.68 - $3.42 $83,294 - $169,563	49,580 New	49,580 $152,000
Q4 2017 Feb 09, 2018	SELL	$3.12 - $4.94 $76,973 - $121,874	-24,671 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$3.42 - $4.87 $84,374 - $120,147	24,671	24,671 $0

Others Institutions Holding AVXL

# of Institutions

159

Shares Held

31.6M

Call Options Held

910K

Put Options Held

1.35M

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $321M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Anavex Life Sciences Corp. Transaction History